Literature DB >> 22949771

Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Armin Barekatain1, Mehdi Razavi.   

Abstract

Entities:  

Keywords:  Anti-arrhythmia agents/classification/therapeutic use; adrenergic betaantagonists; atrial fibrillation/drug therapy; calcium channel blockers; heart rate/drug effects; potassium channel blockers; sodium channel blockers

Mesh：

Substances：

Year:  2012        PMID： 22949771      PMCID： PMC3423266     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  17 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Safe and effective pharmacologic management of arrhythmias.

Authors:  Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2005

3.  Reverse use dependence of antiarrhythmic class Ia, Ib, and Ic: effects of drugs on the action potential duration?

Authors:  H Langenfeld; C Köhler; J Weirich; M Kirstein; K Kochsiek
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

Review 4.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 5.  Classification of antidysrhythmic drugs.

Authors:  E M Vaughan Williams
Journal:  Pharmacol Ther B       Date:  1975

6.  The multiple modes of action of propafenone.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Eur Heart J       Date:  1984-02       Impact factor: 29.983

7.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

8.  Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.

Authors:  S Ranger; M Talajic; R Lemery; D Roy; C Villemaire; S Nattel
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

9.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation.

Authors:  I A Khan
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

10.  Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.

Authors:  G V Naccarelli; P Dorian; S H Hohnloser; P Coumel
Journal:  Am J Cardiol       Date:  1996-01-25       Impact factor: 2.778
View more
  3 in total

1.  Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.

Authors:  Mohammed El Amine Ghembaza; Ali Lounici
Journal:  Indian J Gastroenterol       Date:  2016-07

Review 2.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

3.  Atrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics.

Authors:  Carlos Sánchez; Alfonso Bueno-Orovio; Esther Pueyo; Blanca Rodríguez
Journal:  Front Bioeng Biotechnol       Date:  2017-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.